Navigation
Recherche
|
The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
mercredi 23 octobre 2024, 16:27 , par Wired: Tech.
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders.
https://www.wired.com/story/novo-nordisk-ozempic-compounded-fda-block-pharmacies/
Voir aussi |
56 sources (32 en français)
Date Actuelle
dim. 22 déc. - 22:40 CET
|